Already a member? Sign in
Category: Prescription Drugs
Most Popular Types: Relpax
Generic Name: Eletriptan
A drug used to treat the symptoms of migraine headache (severe throbbing headache that sometimes comes along with nausea and sensitivity to sound and light). It is in a class of medications called selective serotonin receptor agonists.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Migraine | 95 | 20 |
|
|
|
|
|
| Migraine headaches | 77 | 14 |
|
|
|
||
| Other | 7 | 3 |
|
|
|
||
| Headaches | 5 | 2 |
|
|
|||
| Prevent migraine | 3 | 0 | |||||
| Atypical Migraine | 3 | 0 |
See all 130 patients currently taking Eletriptan
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Eletriptan
| Dizziness | 3 | |
|---|---|---|
| Sleepiness | 2 | |
| Grogginess | 2 | |
| Sedation | 1 | |
| Nausea and vomiting | 1 | |
| Chest tightness | 1 | |
| See all 10 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Eletriptan. See all 15 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Did not seem to work | 30 | ||
| Side effects too severe | 11 | ||
| Other | 10 | ||
| Doctor's advice | 8 | ||
| Expense | 8 | ||
| Change in health plan coverage | 4 | ||
| Course of treatment ended | 2 | ||
| Not indicated | 2 | ||
| Personal research | 1 |
Adherence
Taking treatment as prescribed
Adherence of Eletriptan
Always |
28 | 72% |
|
|---|---|---|---|
Usually |
8 | 21% |
|
Sometimes |
2 | 5% |
|
Never |
1 | 3% |
|
Burden
Difficulty being on treatment
Burden of Eletriptan
Very |
0 | 0% |
|
|---|---|---|---|
Somewhat |
6 | 15% |
|
A little |
6 | 15% |
|
Not at all |
27 | 69% |
|
Cost
Paid out of pocket
Cost of Eletriptan
$200+ |
2 | 8% |
|
|---|---|---|---|
$100-199 |
2 | 8% |
|
$50-99 |
5 | 19% |
|
$25-49 |
5 | 19% |
|
< $25 |
12 | 46% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on May 28, 2012.